The controlled substances listed in this section are included in Schedule I: 1. Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation: West Virginia; Several other states require gabapentin prescriptions to be monitored, allowing authorities to detect potential misuse: Campbell L, et al. (2021). Gabapentin controlled Gabapentin (Neurontin) is not a narcotic or federally controlled substance by the DEA as of November 2022, but it is classified as a Schedule V controlled substance in certain states. The 2019 Virginia General Assembly recently passed a new bill that will classify gabapentin as a Schedule V substance starting July 1, 2019. Currently, gabapentin is classified as a Schedule VI drug of concern. This change in schedule will require gabapentin to be reported to the Virginia Prescription Monitoring Program as a schedule V substance. WV CONTROLLED SUBSTANCES MONITORING PROGRAM 2018 ANNUAL REPORT Introduction The West Virginia Controlled Substances Monitoring Program (CSMP) is a central repository, maintained by the West Virginia Board of Pharmacy, for collected data related to the prescription and dispensing of all Schedule II, II and IV controlled substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts: However, due to a spike in gabapentin-related fatalities, Ohio, Kentucky and West Virginia have moved to list the drug as a controlled substance at the state level. Other states are recognizing the growing abuse problem with gabapentin and have, at the very least, mandated that it be included in their prescription drug monitoring programs. In the state of Kentucky, prescribers without a DEA license are unable to prescribe gabapentin after it was classified as a Schedule V controlled substance. 38 This licensing requirement is part of the state’s Controlled Substances Act which had the greatest impact on mid-level practitioners who may not have a DEA license. Kentucky The effectiveness of different strategies, such as policies regarding opioid abuse that regulate access to controlled drugs or the education of patients and prescribers and patients on the addictiveness of gabapentin or restricting supply, is still in question in West Virginia. In Virginia, gabapentin is classified as a Schedule V controlled substance under section 54.1-3454. This classification places it among substances with a lower potential for abuse relative to those in Schedules I through IV. The 2019 Virginia General Assembly passed HB2557 which classifies gabapentin as a Schedule V controlled substance as of July 1, 2019. Until then, gabapentin remains a drug of concern classified as a Schedule VI controlled substance. The Board may promulgate regulations designating specific drugs and substances, including any controlled substance or other drug or substance where there has been or there is the actual or relative potential for abuse, as drugs of concern. Gabapentin isn’t a controlled substance according to the federal government. But several states have passed their own laws classifying gabapentin a schedule V (schedule 5) controlled substance. Combining gabapentin and opioids can be extremely dangerous. schedule V drug under the Controlled Substances Act in its chemical structure and pharmacological activity. The chemical structure of gabapentin is derived from the addition of a lipophilic cyclohexyl group to the backbone of gamma-aminobutyric acid (GABA). Gabapentin is a crystalline substance and freely soluble in water, alkaline and acidic Justia Free Databases of U.S. Laws, Codes & Statutes. 2024 West Virginia Code Chapter 60A. Uniform Controlled Substances Act Article 2. Standards and Schedules §60A-2-212. . Sch WV Board of Pharmacy 1207 Quarrier Street, 4th Floor Charleston, WV 25301 Phone: 304-558-0558 Fax: 304-558-0572 Email: Contact Form | boardofpharmacy@wv.gov Gabapentin is frequently combined with other substances for the purpose of potentiating the effects of the drugs or achieving a “high.” Studies have identified various substances that are commonly abused in combination with gabapentin, including alcohol, opioids, benzodiazepines, antidepressants, and other CNS depressants 13,14,15. Gabapentin, a Schedule V drug in the Commonwealth, had previously been considered a “drug of concern” in Virginia. The 2019 Virginia General Assembly passed HB2557, which classified gabapentin as a Schedule V controlled substance as of July 1, 2019. §60A-2-212. Schedule V. (a) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() |